206 related articles for article (PubMed ID: 25433982)
1. Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST).
Rasmussen JF; Siersma V; Pedersen JH; Brodersen J
Lung Cancer; 2015 Jan; 87(1):65-72. PubMed ID: 25433982
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial consequences of false positives in the Danish Lung Cancer CT Screening Trial: a nested matched cohort study.
Rasmussen JF; Siersma V; Malmqvist J; Brodersen J
BMJ Open; 2020 Jun; 10(6):e034682. PubMed ID: 32503869
[TBL] [Abstract][Full Text] [Related]
3. Participation bias in a randomised trial of screening for lung cancer.
Hestbech MS; Siersma V; Dirksen A; Pedersen JH; Brodersen J
Lung Cancer; 2011 Sep; 73(3):325-31. PubMed ID: 21324544
[TBL] [Abstract][Full Text] [Related]
4. Direct and indirect healthcare costs of lung cancer CT screening in Denmark: a registry study.
Jensen MD; Siersma V; Rasmussen JF; Brodersen J
BMJ Open; 2020 Jan; 10(1):e031768. PubMed ID: 31969362
[TBL] [Abstract][Full Text] [Related]
5. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme.
Ashraf H; Saghir Z; Dirksen A; Pedersen JH; Thomsen LH; Døssing M; Tønnesen P
Thorax; 2014 Jun; 69(6):574-9. PubMed ID: 24443174
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial consequences of a three-month follow-up after receiving an abnormal lung cancer CT-screening result: A longitudinal survey.
Damhus CS; Quentin JG; Malmqvist J; Siersma V; Brodersen J
Lung Cancer; 2021 May; 155():46-52. PubMed ID: 33725548
[TBL] [Abstract][Full Text] [Related]
7. Contamination during 4 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST).
Saghir Z; Ashraf H; Dirksen A; Brodersen J; Pedersen JH
Lung Cancer; 2011 Mar; 71(3):323-7. PubMed ID: 20619924
[TBL] [Abstract][Full Text] [Related]
8. Did psychosocial status, sociodemographics and smoking status affect non-attendance in control participants in the Danish Lung Cancer Screening Trial? A nested observational study.
Malmqvist J; Siersma V; Thorsen H; Heleno B; Rasmussen JF; Brodersen J
BMJ Open; 2020 Feb; 10(2):e030871. PubMed ID: 32086352
[TBL] [Abstract][Full Text] [Related]
9. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST).
Ashraf H; Tønnesen P; Holst Pedersen J; Dirksen A; Thorsen H; Døssing M
Thorax; 2009 May; 64(5):388-92. PubMed ID: 19052048
[TBL] [Abstract][Full Text] [Related]
10. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
[TBL] [Abstract][Full Text] [Related]
11. Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: a registry study.
Rasmussen JF; Siersma V; Pedersen JH; Heleno B; Saghir Z; Brodersen J
Lung Cancer; 2014 Mar; 83(3):347-55. PubMed ID: 24418526
[TBL] [Abstract][Full Text] [Related]
12. Consequences of screening in lung cancer: development and dimensionality of a questionnaire.
Brodersen J; Thorsen H; Kreiner S
Value Health; 2010 Aug; 13(5):601-12. PubMed ID: 20345552
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial.
Aggestrup LM; Hestbech MS; Siersma V; Pedersen JH; Brodersen J
BMJ Open; 2012; 2(2):e000663. PubMed ID: 22382119
[TBL] [Abstract][Full Text] [Related]
14. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
[TBL] [Abstract][Full Text] [Related]
15. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
[TBL] [Abstract][Full Text] [Related]
16. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
Pedersen JH; Ashraf H; Dirksen A; Bach K; Hansen H; Toennesen P; Thorsen H; Brodersen J; Skov BG; Døssing M; Mortensen J; Richter K; Clementsen P; Seersholm N
J Thorac Oncol; 2009 May; 4(5):608-14. PubMed ID: 19357536
[TBL] [Abstract][Full Text] [Related]
17. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial).
van den Bergh KA; Essink-Bot ML; Bunge EM; Scholten ET; Prokop M; van Iersel CA; van Klaveren RJ; de Koning HJ
Cancer; 2008 Jul; 113(2):396-404. PubMed ID: 18484588
[TBL] [Abstract][Full Text] [Related]
18. CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication.
Kaerlev L; Iachina M; Pedersen JH; Green A; Nørgård BM
BMC Cancer; 2012 May; 12():188. PubMed ID: 22621716
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
20. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
